Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 16Psoriasis 7Leukemia 5Lymphoma, Follicular 4Spondylitis, Ankylosing 3Myelodysplastic Syndromes 3Inflammation 3Asthma 3Arthritis, Juvenile 3Vasculitis 2Uveitis 2Respiratory Distress Syndrome 2Recurrence 2Prostatic Neoplasms 2Pneumonia 2Neuroblastoma 2Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Granulomatosis with Polyangiitis 2Bronchiolitis Obliterans 2Arthritis, Psoriatic 2Wilms Tumor 1Temporomandibular Joint Disorders 1Stomatitis 1Spondylarthritis 1Pruritus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Thoracotomy 1Thoracic Surgery, Video-Assisted 1Sodium Chloride 1Saline Solution 1Polypropylenes 1Polyglactin 910 1Etanercept 1Drug Delivery Systems 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Injury × Etanercept × Clear all
NCT00141726 2015-12-03

Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant

University of Michigan Rogel Cancer Center

Phase 2 Completed
34 enrolled 13 charts

Bronchiolitis Obliterans, Respiratory Distress Syndrome, Lung Injury, Acute Lung Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡